Archive for February, 2015

Misconduct

“Fifty-seven published clinical trials were identified for which an FDA inspection of a trial site had found significant evidence of 1 or more of the following problems: falsification or submission of false information, 22...

Read More

Scientific Misconduct

JAMA Internal Medicine report that highlights an important area for improved public reporting of clinical trials and enhanced transparency at the US Food and Drug Administration (FDA). Read the Report Here: misconduct ied140005

Read More

SBA Outlines New Mentor-Protégé Program, Proposed Rule

The Small Business Administration issued a proposed rule Thursday that would consolidate existing mentor-protégé programs into a single government-wide program that would be available to all small business contractors, as well as making other...

Read More